Topic: preclinical research

Pierre Fabre buys up Igenica preclinical I-O meds

Pierre Fabre, the second biggest biopharma in France (after Big Pharma Sanofi), is boosting its cancer pipeline with what it is dubbing “promising” immuno-oncology candidates from California’s Igenica Biotherapeutics.